Kamath believes affordability is no longer the biggest obstacle. According to him, convincing people to remain on a weekly ...

Biocon's executive chairperson says lifestyle changes should remain the first choice, while Zerodha's founder says generic ...

India’s much-hyped weight-loss drug market may not be taking off as expected. Despite obesity rates rising and generic GLP-1 ...